Ga-68 PSMA-093

N/A

Report date: 2025/11/26 17:11:16
NME

Base Information

Drug NameGa-68 PSMA-093
Drug Alias NameGallium-68 P16-093Ga-68 P16-093PSMA-93 LatestPSMA-093HBED-CC-PHENOXY-PSMA +[6] 
ClassificationSmall moleculesDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionPositron-emission tomography enhancersRadionuclide imaging enhancersEmission-computed tomography enhancers +[4] 
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsSjogren's SyndromeKidney NeoplasmsProstatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesIndiana UniversityPeking Union Medical College HospitalFive Eleven Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeking Union Medical College HospitalIndiana UniversityFive Eleven Pharma Inc
Inactive CompaniesN/A
Active IndicationsSjogren's SyndromeKidney NeoplasmsProstatic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A